Adalimumab vs Deucravacitinib

## Adalimumab vs Deucravacitinib: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Deucravacitinib**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Deucravacitinib — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Deucravacitinib — Small molecule.